|
Volumn 23, Issue 11 Suppl, 2004, Pages 1365-1369
|
Effect of epidermal growth factor receptor-selective tyrosine kinase inhibitor gefitinib on nasopharyngeal carcinoma xenografts
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
EPIDERMAL GROWTH FACTOR RECEPTOR;
GEFITINIB;
PROTEIN KINASE INHIBITOR;
PROTEIN TYROSINE KINASE;
QUINAZOLINE DERIVATIVE;
ANIMAL;
ARTICLE;
BAGG ALBINO MOUSE;
BODY WEIGHT;
CANCER TRANSPLANTATION;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG POTENTIATION;
FEMALE;
MALE;
MOUSE;
NASOPHARYNX TUMOR;
NUDE MOUSE;
PATHOLOGY;
RANDOMIZATION;
TUMOR CELL LINE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BODY WEIGHT;
CELL LINE, TUMOR;
CISPLATIN;
DRUG SYNERGISM;
FEMALE;
MALE;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
NASOPHARYNGEAL NEOPLASMS;
NEOPLASM TRANSPLANTATION;
PROTEIN KINASE INHIBITORS;
PROTEIN-TYROSINE KINASES;
QUINAZOLINES;
RANDOM ALLOCATION;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
EID: 28744447772
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|